Green Square Capital Advisors LLC P Lx Pharma Inc. Transaction History

Green Square Capital Advisors LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 15, 2023	BUY	$0.15 - $0.63 $119,100 - $500,220	794,000 Added 411.4%	987,000 $157,000
Q3 2022 Oct 31, 2022	BUY	$0.52 - $3.08 $95,160 - $563,640	183,000 Added 1830.0%	193,000 $125,000
Q2 2022 Jul 20, 2022	BUY	$1.9 - $4.18 $19,000 - $41,800	10,000 New	10,000 $24,000
Q1 2022 May 05, 2022	SELL	$3.54 - $8.3 $20,532 - $48,140	-5,800 Closed	0 $0
Q4 2021 Mar 08, 2022	BUY	$7.69 - $19.66 $44,602 - $114,028	5,800 New	5,800 $46,000

62.7K

Ticker PLXP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 29,137,700
Description
PLx Pharma Inc. operates as a commercial-stage drug delivery platform technology company in the United States. The company's lead product candidates are Vazalore 325 mg for the patients with vascular events, such as heart attacks and clot-related strokes, as well as for use in conditions associated with pain and inflammation, including other asp...

Get notified when there are updates to the investment portfolio of Green Square Capital Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Green Square Capital Advisors LLC with notifications on news.